Invention Grant
- Patent Title: Liposome formulation of fluticasone furoate and method of preparation
-
Application No.: US17001889Application Date: 2020-08-25
-
Publication No.: US11304901B2Publication Date: 2022-04-19
- Inventor: Cai Gu Huang , Hailong Zhang , Abid Hussain
- Applicant: ANOVENT PHARMACEUTICAL (U.S.), LLC
- Applicant Address: US NJ Newark
- Assignee: ANOVENT PHARMACEUTICAL (U.S.), LLC
- Current Assignee: ANOVENT PHARMACEUTICAL (U.S.), LLC
- Current Assignee Address: US NJ Newark
- Agency: Parker Poe Adams & Bernstein LLP
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K31/58 ; B01F21/00 ; A61K47/02 ; A61K47/22 ; A61K47/20

Abstract:
The present invention is directed to a liposomal formulation having a lipid ingredient encapsulating fluticasone furoate, and a method for preparing the liposomal formulation. The liposome formulation comprises a lipid and a sterol. The method of preparing the liposomes comprises the steps of (1) mixing fluticasone furoate with lipid ingredients comprising a lipid and a sterol, (2) injecting the mixture into normal saline solution, and (3) ultrafiltering and concentrating the resulting solution. This preparation method can produce a liposome formulation having desirable properties and compositions, for example, the ratio of the lipid ingredient, the drug to lipid ratio, and the pH value, which is suitable for nebulization inhalation.
Public/Granted literature
- US20210059937A1 Liposome Formulation of Fluticasone Furoate and Method of Preparation Public/Granted day:2021-03-04
Information query